Our lab is interested in understanding the genome regulatory mechanisms that control the differentiation and function of pancreatic insulin-producing ß-cells. We use this information to gain insights into the molecular defects that cause different forms of diabetes. This knowledge is also very relevant for the generation of new insulin-producing cells for replacement therapies in Type 1 diabetes. Genetic analysis of beta-cell regulation. Understanding the epigenome of pancreatic islets. UK, as well as in.

A resource for physicians established by the Endocrine Society. Earn continuing medical educational credit. Working with the Endocrine Society, Beta Cells in Diabetes now offers CME opportunities. CME Activities are available on our CME page. Find out more about beta cell physiology. On how to target beta cell function early in the course of type 2 diabetes or visit our BetaCell Science section. Learn what it means to patient care.

The Center for Beta Cell Therapy in Diabetes. Is an international center for the study, prevention and treatment of diabetes. More specifically, it aims to develop and implement interventions that restore a functional beta cell mass in patients with type 1 diabetes. This requires methods that replace the lost beta cells and protect beta cells. The Center organizes and coordinates a Research and Development Platform. Both undertaken by an International Consortium.

Welcome to the Avira Beta Community. Learn more about this Community here.

Beta Kutató Intézet Nonprofit Kft.